Evidence map›Paper›PMID 42074948›Full record

ReviewJournal of clinical medicine2026

Cytisine-New Challenges of a Well-Known Drug in the Treatment of Nicotine Addiction.

Lidia Bieniasz, Karol Wróblewski, Angelika Kamizela, Agnieszka Szyszkowska, Waldemar Grzegorzewski, Anna Czerniecka-Kubicka

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lidia BieniaszDepartment of Drug Form Technology and Medical Physics, Faculty of Medicine, Collegium Medicum, University of Rzeszów, 35-310 Rzeszów, Poland.
Karol WróblewskiLaboratory of Commercial and Non-Commercial Clinical Trials, Medical College of Rzeszow University, University of Rzeszow, 35-310 Rzeszow, Poland.
Angelika KamizelaDepartment of Drug Form Technology and Medical Physics, Faculty of Medicine, Collegium Medicum, University of Rzeszów, 35-310 Rzeszów, Poland.ORCID 0000-0001-5565-2100
Agnieszka SzyszkowskaDepartment of Drug Form Technology and Medical Physics, Faculty of Medicine, Collegium Medicum, University of Rzeszów, 35-310 Rzeszów, Poland.ORCID 0009-0003-2086-7832
Waldemar GrzegorzewskiFaculty of Biology, Nature Conservation and Sustainable Development, University of Rzeszów, 35-310 Rzeszów, Poland.ORCID 0000-0002-3522-1327
Anna Czerniecka-KubickaDepartment of Drug Form Technology and Medical Physics, Faculty of Medicine, Collegium Medicum, University of Rzeszów, 35-310 Rzeszów, Poland.

Funding

Agencja Badań Medycznych KPOD.07.07-IW.07-0142/24
6 · The paper itself

Abstract

Cytisine is a plant-derived quinolizidine alkaloid found, among other sources, in the seeds of the common laburnum (

Indexed as

cytisinenicotine addictionpharmacotherapy

Identifiers

PMID42074948
PMCPMC13116723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.